GSP Crop Science Limited has informed the Exchange about Investor Presentation
GSP CROP SCIENCE LIMITED (Ea rlier know n as GSP Crop Science Private Limited ) A Regd. & Corp . Office : 404, Lolita Compl ex, Rasala Road, Mitha kha li Six Road, V Navran gpura, Ahm edabad-380009, Gu jarat, India. ' - ' + 91 -79-61915111, 6191515 1, 26449936 C, info@gspcrop.in www. gspcrop.in I CIN: U24120GJ1985P L C007641 f @
in a
Date: April 17, 2026
BSE Limited Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai – 400 001
Scrip Code: 544733
Dear Sir/Madam,
National Stock Exchange of India Limited Exchange Plaza, Plot No. C/1, G Block, Bandra Kurla Complex, Bandra (East), Mumbai – 400 051
Trading Symbol: GSPCROP
Sub: Investor Presentation of the Earnings Conference Call
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and in continuation of our letter dated April 13, 2026 regarding schedule of Earning Conference Call, please find attached herewith the Investor Presentation for the Third quarter and nine month ended December 31, 2025. The same is also available on the website of the Company at www.gspcrop.in.
You are requested to take the same on your record.
Thanking you. Yours faithfully, For GSP Crop Science Limited
Kamleshbhai D Patel Company Secretary & Compliance Officer M. No. FCS 8018
Encl: As above
~~ Certificale Number 5774 CerTJ:ib:C,'~U:•ir 5984
ISO 9001 ISO 14001
ISO l-400l 150 45001
Q3 & 9M FY26
RESULTS PRESENTATION
GSP Crop Science Limited
17.04.2026
01
Business Overview
GSP Crop Science– Business Overview
Product Portfolio : Insecticides, Herbicides, Fungicides and Plant Growth Regulators
Domestic
Exports
• • • • • •
•
Domestic B2B & B2C Business of Technical & Formulation Formulation portfolio of 219 registration Technical portfolio of 63 registration Present in 23 States, Strong Dealer/Distributor Network Long Standing Relationship with Customers Associated for 10 years+ Granted 102 Patents & 108 patent applications under process
St.1.,.&UT• highlipltcd"'hru OSP Crop Scia1Ce Limited bas ~anddi<tribtdioo1lffi0..,.1,:
lo, """'"
Odh.-,•,Ahmed.lt,.,i
~ Ka11,,..'IKII. Ahmedabad
la, Naodesari. \'ldodanl
la, sayl:ha.Dahej
• •
Global Reach : Operating in 37 countries Export Registrations : 176 Formulations and 60 Technical product registrations
•••<Jl•1
HO!IQ (Q"9
9uAC
~ l-d• fhd
$'1 Un Moll
Kt"l'/J . ...,,,.
91, ... .-
rt
Ph liJ,:Jifll"\
(hno
501,thAlr'
GSP Crop Science– Key Strengths
Well-diversified product portfolio including a wide range of insecticides, herbicides, fungicides, and plant growth regulators, making us a comprehensive solution provider for our customers
01
Led by qualified and experienced Promoters and supported by a professional management team
05
Catering to a large and diverse clientele both domestically as well as internationally
02
04
03
Robust manufacturing facilities with ability to manufacture a wide range of products with a focus on sustainability
Strong in-house R&D capabilities with focus on innovation and product development
GSP Crop Science - Strong in-house R&D capabilities
Strong IP Portfolio
Strategic Focus on Innovation and Product Development
~ 1~
102 granted patents 108 applications under process
10 exclusive process patents for Technical products
0
gfl[]
Ranked among Top 10 Indian applicants for • Patent cooperation Treaty filings in FY 22
• Scientific & Research and Development
Organization patents in FY17
Innovation – Driven R&D Capabilities
We undertake R&D activities as part of our operations which has enabled us to develop the technological processes we utilize at our facilities
Significant emphasis on Identifying formulations and technical for commercialization
1
3
2
l '
4
Track record of introducing Formulations and Technicals to the Indian agrochemical market
Continuously explores innovative production methods to enhance efficiency and product quality
Patented Products and Registrations
Registration
Formulations (Indigenous Manufacture)
Technicals (Indigenous Manufacture)
Technicals (Import)
9 (3)
9 (4)
16
203
10
53
1
5
Total
27
261
\
I
I
-:@r
I
I
\
We are among the first indigenous manufacturers of certain technicals used in our approved formulations and also hold exclusive patents.
Capable of handling complex chemistries
l
§ 1
§ 2
I
Chlorantraniliprole Technical (≥96% purity)
Clothianidin Technical (≥98% purity)
Pymetrozine Technical (≥98% purity)
In addition to 288 registrations under Sections 9(3) and 9(4), we hold:
- Export registrations for 176 Formulations, and
- 66 Technicals exclusively for overseas markets.
Key brands manufactured by GSP include: SLR 525, Platform, PCT-410, All Rounder, Afford, Aurthor, Liger, Raavan, and Element.
--------- ■
Total
219
63
6
288
§3 The combination of patented technology and regulatory licensing denotes the production capabilities are unique and approved to use, considered as significant differentiating factor.
GSP Crop Science– Customer Engagement
PRODUCT PROMOTION
FARMER ENGAGEMENT
CHANNEL ENGAGEMENT
Building lasting relationships with trade partners and establishing loyalty with customers
GSP Crop Science : Manufacturing Facilities
Operating Five manufacturing facilities in India
Certifications
Odhav Facility
Installed Capacity
Formulations
27,132.00 MT
Technicals
3,960.00 MT
Kathwada Facility
Installed Capacity
Formulations
6,000.00 MT
Nandesari Facility
Installed Capacity
Technicals
11,160.00 MT
Samba Facility
Installed Capacity
Formulations
10,540.00 MT
Saykha Facility
Installed Capacity
Intermediates
5,400 MT
~
ISO
~
9001 :2015
~
ISO
~
45001 :2018
Highlights : Business Performance
Domestic B2C (Brand )Business
International Business
Synthesis R&D
New Products – Launched one patented Insecticide + Fungicide mixture in Paddy & introduced two me-to & Maize Soybean herbicides in India B2C market.
Geography
New – Expanded sales operation to Kerala ,starting with one territory ,operating under Tamil Nadu region focusing on plantation crops .
-
in
LY
Brazil
Exports The performance of International Business revenue is + 20% over LY coming from planned sales of products in Brazil , USA and Africa region. The new registration received for Chlorpyriphos helped in better sales. This year the company has already including source initiated product registrations , Africa , Middle East and Asian countries to increase our offerings in the future. The registration focus in the period has been on Chlorantriniliprole and Methoxyfenzoide.
in Brazil
on
futuristic
Initiated work 2 insecticides & one herbicide active ingredients from IP perspective to early entry in market when their patents expire in near future. Applied for 10 herbicides , insecticides & fungicides technical(a.i’s) registration for export only and got approval for some, others in progress ; Filed 8 9(4)/9(3) molecules technical registrations & some are approved ,others in progress.
Strong focus on digital channels to drive customer and retailer engagement
02
Financial Performance
Highlights : Consolidated Financial Performance (Q3 & 9M FY 2026)
(INR in Million)
REVENUE
EBITDA
9M Growth 14%
11,146
9,794
4,673
4,054
3,770
2,981
2,759
2,704
939
663
471
449
9M Growth 32%
1,538
1,168
150
33
Q1
Q2
FY 2025
Q3 FY 2026
9M
Q1
Q2
Q3
9M
FY 2025
FY 2026
Ø 9MFY26 revenue increased by 14% from ₹ 9794 Million in 9MFY25 to ₹ 11146 Million in 9MFY26
Ø The growth in revenue is mainly attributed to increase of business under domestic B2C segment
Ø 9MFY26 EBITDA increased by 32% from ₹ 1168 Million in 9MFY25 to ₹ 1538 Million in 9MFY26
Ø EBITDA Margin increased from 11.92% in
9MFY25 to 13.80% in 9MFY26
PAT
585
9M Growth 26%
393
751
596
266
226
Q1
Q2
Q3
-62
-60
9M
FY 2025
FY 2026
Ø 9MFY26 PAT increased by 26% from ₹596 Million in 9MFY25 to ₹751 Million in 9MFY26
Ø PAT Margin
increased
from 6.09% in
9MFY25 to 6.74% in 9MFY26
Ø Under B2C segment, Increase In revenue mainly due To New Product Sale ₹366.00 million and overall sales increase in PCT-410 by ₹80.00 million, Torch by ₹ 107.00 million, Aurthor by ₹90.00 million, and Runout by ₹ 47.00 million.
Ø The growth in EBITDA is mainly attributed higher business volume under B2C segment in 9MFY26 as compared to business volume under B2C segment in 9MFY25
Strong focus on digital channels to drive customer and retailer engagement
Highlights : Standalone Financial Performance (Q3 & 9M FY 2026)
(INR in Million)
REVENUE
9M Growth 9%
11,766
10,799
EBITDA
9M Growth 23%
721
1,296
1,058
PAT
9M Growth 28%
464
682
533
4,299
4,002
3,543
4,997
2,957
2,766
422
435
472
244
227
257
164
140
49
Q1
Q2
FY 2025
■
Q3 FY 2026
■
9M
Q1
Q2
FY 2025
■
Q3 FY 2026
■
9M
Q1
Q2
Q3
-26
9M
FY 2025
■
FY 2026
■
Ø 9MFY26 revenue increased by 9% from ₹10799 Million in 9MFY25 to ₹11766 Million in 9MFY26
Ø 9MFY26 EBITDA increased by 23% from ₹ 1058 Million in 9MFY25 to ₹ 1296 Million in 9MFY26
Ø 9MFY26 PAT increased by 28% from ₹533 Million in 9MFY25 to ₹682 Million in 9MFY26
Ø The growth in revenue is mainly attributed to increase of business under domestic B2C segment
Ø EBITDA Margin increased from 9.79% in
9MFY25 to 11.01% in 9MFY26
Ø PAT Margin
increased
from 4.93% in
9MFY25 to 5.80% in 9MFY26
Ø Under B2C segment, Increase In revenue mainly due To New Product Sale ₹366.00 million and overall sales increase in PCT-410 by ₹80.00 million, Torch by ₹ 107.00 million, Aurthor by ₹90.00 million, and Runout by ₹ 47.00 million.
Ø The growth in EBITDA is mainly attributed higher business volume under B2C segment in 9MFY26 as compared to business volume under B2C segment in 9MFY25
Strong focus on digital channels to drive customer and retailer engagement
Thank You
GSP CROP SCIENCE LIMITED 404, Lalita Complex, 352/3, Rasala Marg, near Jain Temple, Mithakhali, Navrangpura, Ahmedabad, Gujarat 380009 Email: cs@gspcrop.com
https://www.gspcrop.in/